Eric Bjerkholt, EVP, CFO & Corp. Secretary at Viracta Therapeutics, holds 261.68K shares in Cerus (Ticker: CERS), holds 47.18K shares in Mirum Pharmaceuticals (Ticker: MIRM), holds 0.00 shares in Chinook Therapeutics (Ticker: KDNY). Most recently, Eric Bjerkholt Sold ― shares of Cerus on Jun 11, 2026 for an estimated value of $53.18K.
Eric Bjerkholt latest transaction was an Informative Sell of $53.18K.
What was Eric Bjerkholt's most profitable transaction?
Eric Bjerkholt’s most profitable transaction was an Informative Buy of CALC stock on May 18, 2023. The return on the trade was 107.60%.
What is Eric Bjerkholt's role in Viracta Therapeutics?
Eric Bjerkholt's role in Viracta Therapeutics is EVP, CFO & Corp. Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.